Feature | July 09, 2008| Cristen Bolan

Cardiologists, Payers Set Out on Imaging Track

Cardiology fellows are expanding their knowledge in cardiovascular imaging. Not only do virtually all cardiology fellows get Level 2 training in echocardiography and many in nuclear cardiology but now, an increasing number of fellows are training in cardiac MR and cardiac CT.

For those cardiologists who did not receive such training, continuing medical education (CME) offerings and preceptorships enable them to acquire new skills in cardiac MR and cardiac CT.

Facilitating the imaging training paradigm is the development of a set of appropriateness criteria. Recently, the following cardiology societies, ACCF, ASE, ACEP, AHA, ASNC, SCAI, SCCT, SCMR, jointly issued the 2008 appropriateness criteria for stress echocardiography. Now, updates on criteria for cardiac CT and MR are underway.

Of course, one of the key objectives is to improve patient outcome. In the article, “Are Cardiologists the QB’s of Cardiac Imaging?,” appearing in this issue, appropriateness criteria is designed to, for example, prevent a coronary CT scan for a patient with an unstable coronary syndrome or a patient who has high creatinine or renal insufficiency. Mark A. Turco, M.D., points out in the article that these guidelines are critical to ensure the best information is provided to the physicians for making the best treatment decisions.

But is it all about the patients? You don’t need to look too far before you see the other driving force behind such an initiative – the payers. With pay-for-performance these guidelines will not only educate cardiologists but should also guide the third-party payers in making reimbursement decisions. In light of the Deficit Reduction Act (DRA) and sweeping reimbursement cuts enacted to meet arbitrary budget targets, let’s just hope that the payers get their imaging education too, before patients and the decisions doctors make to care for them represent little more than dollar signs.

Related Content

Toshiba, Infinix 4-D CT, first U.S. install, Arkansas cancer center
News | CT Angiography (CTA)| May 26, 2016
Cancer patients at the Carti Cancer Center, Conway, Ark., now have access to the latest innovation in diagnostic...
cardiac magnetic resonance, CMR, breathing, high frequency percussive ventilation, EuroCMR 2016
News | Magnetic Resonance Imaging (MRI)| May 24, 2016
A new technique for cardiac magnetic resonance (CMR) imaging improves accuracy by removing patients' need to breathe,...
HeartFlow, FFR-CT, ruptured coronary plaques, EMERALD study, EuroPCR 2016
News | CT Angiography (CTA)| May 23, 2016
First-in-human data presented at EuroPCR 2016 demonstrate that hemodynamic data from HeartFlow Inc. may help predict...
Technology | Cardiac Imaging| May 18, 2016
May 18, 2016 — The Intersocietal Accreditation Commission (IAC) recently announced its launch of the IAC QI Self-Asse
Johns Hopkins, virtual heart modeling tool, VARP, arrhythmias, implanted defibrillator

Examples of how the computer model would classify one patient at high risk for heart arrhythmia and another at low risk. Image courtesy of Royc Faddis/Johns Hopkins University.

News | Cardiac Diagnostics| May 17, 2016
May 17, 2016 — An interdisciplinary Johns Hopkins University team has developed a...
Radiation dose management, radiation dose monitoring, X-ray dose

Analytics from Sectra’s radiation dose monitoring software showing procedures where dose levels were higher than normal for various X-ray modalities. 

Feature | Radiation Dose Management| May 12, 2016 | Lori Webb, R.T. (R) and Tom Watson, RCVT
Healthcare organizations, clinicians and medical equipment manufacturers have long focused on the management and redu
Imricor, Vision-MR ablation catheter, clinical study, MRI guidance
News | Ablation Systems| May 10, 2016
Imricor Medical Systems announced enrollment of the first patients in a clinical study to evaluate the Vision-MR...
Hitachi Medical, Scenaria CT scanner, All-Inclusive Support program
Technology | Computed Tomography (CT)| May 02, 2016
May 2, 2016 — Hitachi Medical Systems America Inc.
MR angiography, MRA, Bayer, Gadavist, gadobutrol injection, FDA approval, supra-aortic arteries
Technology | Contrast Media| April 29, 2016
Bayer announced that the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use...
Overlay Init